1. Home
  2. CIF vs ZYXI Comparison

CIF vs ZYXI Comparison

Compare CIF & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Intermediate High Income Fund

CIF

MFS Intermediate High Income Fund

HOLD

Current Price

$1.71

Market Cap

31.1M

Sector

Finance

ML Signal

HOLD

Logo Zynex Inc.

ZYXI

Zynex Inc.

HOLD

Current Price

$0.29

Market Cap

35.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIF
ZYXI
Founded
1988
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.1M
35.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CIF
ZYXI
Price
$1.71
$0.29
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$3.00
AVG Volume (30 Days)
43.9K
15.1M
Earning Date
01-01-0001
11-17-2025
Dividend Yield
10.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$108,202,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$0.23
52 Week High
$1.77
$8.72

Technical Indicators

Market Signals
Indicator
CIF
ZYXI
Relative Strength Index (RSI) 42.21 32.70
Support Level $1.68 $0.23
Resistance Level $1.76 $0.95
Average True Range (ATR) 0.02 0.16
MACD -0.00 -0.07
Stochastic Oscillator 21.43 4.25

Price Performance

Historical Comparison
CIF
ZYXI

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: